CompaniesMerrion Pharmaceuticals

Merrion Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

1

As Collaborator

3

Total Enrollment

172

By Phase

PHASE4: 1PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1

By Status

COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details

Recent Trials

NCT02892942Collaborator
NATural Ovarian Stimulation
PHASE4Completed
129 participants
Started: Jan 13, 2017 · Completed: Feb 8, 2019
NCT00636740Lead Sponsor
Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients
PHASE2Completed
30 participants
Started: Feb 29, 2008 · Completed: Feb 28, 2009
NCT00603187Collaborator
ACY-7 Oral Administration of Acyline
PHASE1/PHASE2Completed
4 participants
Started: Jan 31, 2008 · Completed: Feb 29, 2008
NCT00471185Collaborator
ACY-6 Oral Administration of Acyline
PHASE1Completed
9 participants
Started: Jun 30, 2007 · Completed: Aug 31, 2007